ICU Medical, Inc. $ICUI Shares Bought by Public Sector Pension Investment Board

Public Sector Pension Investment Board lifted its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 14.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 96,270 shares of the medical instruments supplier’s stock after buying an additional 12,412 shares during the period. Public Sector Pension Investment Board’s holdings in ICU Medical were worth $11,549,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Caprock Group LLC acquired a new position in ICU Medical during the 3rd quarter worth approximately $757,000. Rhumbline Advisers lifted its position in shares of ICU Medical by 0.3% during the third quarter. Rhumbline Advisers now owns 69,191 shares of the medical instruments supplier’s stock worth $8,300,000 after purchasing an additional 210 shares in the last quarter. Bryce Point Capital LLC purchased a new position in shares of ICU Medical in the third quarter valued at $586,000. Smartleaf Asset Management LLC grew its holdings in ICU Medical by 20.2% during the 3rd quarter. Smartleaf Asset Management LLC now owns 1,165 shares of the medical instruments supplier’s stock valued at $136,000 after purchasing an additional 196 shares in the last quarter. Finally, AlphaQuest LLC grew its holdings in ICU Medical by 189.7% during the 3rd quarter. AlphaQuest LLC now owns 4,392 shares of the medical instruments supplier’s stock valued at $527,000 after purchasing an additional 2,876 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Analyst Upgrades and Downgrades

ICUI has been the subject of a number of analyst reports. Wall Street Zen raised ICU Medical from a “hold” rating to a “buy” rating in a report on Sunday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ICU Medical in a research report on Thursday, January 22nd. KeyCorp raised their price target on shares of ICU Medical from $173.00 to $175.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Finally, Piper Sandler upped their price target on shares of ICU Medical from $153.00 to $172.00 and gave the company an “overweight” rating in a report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, ICU Medical has a consensus rating of “Moderate Buy” and an average target price of $175.67.

ICU Medical Stock Performance

Shares of ICUI stock opened at $144.90 on Monday. The company has a market cap of $3.58 billion, a P/E ratio of -467.40 and a beta of 0.79. The business has a 50 day moving average of $148.95 and a two-hundred day moving average of $135.21. ICU Medical, Inc. has a 52 week low of $107.00 and a 52 week high of $165.17. The company has a quick ratio of 1.19, a current ratio of 2.45 and a debt-to-equity ratio of 0.62.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.